ReviewInternational journal of nanomedicine2026
Biomaterials and Nanomedicine for Mucosal Repair and Inflammation Control in Interstitial Cystitis/Bladder Pain Syndrome: An Extensive Review.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Interstitial cystitis (IC), also known as bladder pain syndrome (BPS), is a chronic and devastating urologic disease. Its characteristics include the damage to the barrier function of bladder mucosa, inflammation related to nerve activity and chronic pelvic pain. Traditional treatments often only alleviate symptoms and cannot fundamentally treat this disease. This has inspired to seek new opportunities and strategies to use biomaterials and nanomedicine to reverse tissue damage and pain in patients with this disease. In this review, we comprehensively summarized the latest advances in innovative strategies for bladder mucosal repair and inflammation modulation. This includes glycosaminoglycan mimetics, nanomaterial-based drug delivery systems, stem cells and exosome-based nanomedicine, platelet-rich plasma, and other emerging nanomaterial-related therapeutic approaches. Moreover, we also explored their potential mechanisms of action, valuable results from preclinical and clinical studies, current challenges, and future possibilities for clinical applications. This review may promote the prospect of targeted multifunctional strategies to improve the clinical treatment of IC/BPS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.